Search results
25 paź 2024 · 2 min read. Oct. 25, 2024 – Thousands of bottles of the medicine duloxetine are being recalled because they may contain a potentially cancer-causing agent. Duloxetine is the generic equivalent ...
3 dni temu · Key Takeaways. The FDA issued a recall notice for more than 7,000 bottles of duloxetine, a drug used to treat depression, anxiety, and nerve pain. The recalled lot may contain high levels of nitrosamines, a carcinogenic compound. The recall is Class II, meaning the health harms associated with taking the tainted medication are likely temporary ...
22 paź 2024 · The recall covers 7,107 bottles of duloxetine, the FDA said. The bottles include 500 delayed-release 20mg capsules. The lot number is 220128, with an expiration date of 12/2024.
25 paź 2024 · The voluntary recall was initiated earlier this month by the US Food and Drug Administration. Duloxetine, according to the Cleveland Clinic , treats depression, anxiety, fibromyalgia and chronic pain.
24 paź 2024 · The U.S. Food and Drug Administration announced a Class II recall for more than 7,100 bottles of Duloxetine — a generic antidepressant for Cymbalta — due to a cancerous chemical. A voluntary...
23 paź 2024 · Thousands of bottles of the antidepressant medication duloxetine have been recalled, according to the Food and Drug Administration. The medication, sold under the brand name Cymbalta, contains a ...
23 paź 2024 · The drug is sold under the brand name Cymbalta. The Duloxetine Delayed-Release Capsules' voluntary recall began on Oct. 10 after the FDA deemed the medication the second-highest risk classification. Over 7,100 bottles of Duloxetine were recalled, including 500 delayed-release 20mg capsules.
